ReviewPharmaceuticals (Basel, Switzerland)2025

Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer's Disease.

Melinda Urkon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.